Home › Multiple Myeloma › Idaho
Multiple Myeloma clinical trials in Idaho
3 studies for Multiple Myeloma are looking for participants at sites in Idaho.
Testing the Investigational Medication Combination of Daratumumab and Teclistamab Compared to the Usual Treatment (Daratumumab, Pomalidomide, Dexamethasone or Daratumumab, Carfilzomib, Dexamethasone) for Patients With High-risk Multiple Myeloma Refractory or in First Relapse
- Kootenai Health - Coeur d'Alene, Coeur d'Alene
- Kootenai Clinic Cancer Services - Post Falls, Post Falls
- Kootenai Clinic Cancer Services - Sandpoint, Sandpoint
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06948084Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
- Saint Alphonsus Cancer Care Center-Boise, Boise
- Saint Alphonsus Cancer Care Center-Caldwell, Caldwell
- Saint Alphonsus Cancer Care Center-Nampa, Nampa
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT04566328Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
- Saint Luke's Cancer Institute - Boise, Boise
- Saint Luke's Cancer Institute - Fruitland, Fruitland
- Saint Luke's Cancer Institute - Meridian, Meridian
- and 2 more
RecruitingPhase 3
All ages · All sexes · Updated Jun 10, 2026 · NCT05561387From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.